Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance

D. Falzon (Geneva, Switzerland), N. Ford (Geneva, Switzerland), E. Jaramillo (Geneva, Switzerland), P. Nahid (San Francisco, United States of America), P. Cegielski (Atlanta, United States of America), H. Schunemann (Hamilton, Canada), J. Brozek (Hamilton, Canada), K. Weyer (Geneva, Switzerland)

Source: International Congress 2018 – Drug-resistant tuberculosis
Session: Drug-resistant tuberculosis
Session type: Poster Discussion
Number: 3686
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Falzon (Geneva, Switzerland), N. Ford (Geneva, Switzerland), E. Jaramillo (Geneva, Switzerland), P. Nahid (San Francisco, United States of America), P. Cegielski (Atlanta, United States of America), H. Schunemann (Hamilton, Canada), J. Brozek (Hamilton, Canada), K. Weyer (Geneva, Switzerland). Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance. 3686

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: